Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer

[1]  I. Ellis,et al.  Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer , 2014, BMC Cancer.

[2]  K. Byth,et al.  The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer , 2014, Journal of Clinical Pathology.

[3]  Jack Cuzick,et al.  Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Balleine,et al.  Ki67 and proliferation in breast cancer , 2013, Journal of Clinical Pathology.

[5]  S. Cross,et al.  PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 , 2012, British Journal of Cancer.

[6]  C. Caldas,et al.  Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer , 2012, British Journal of Cancer.

[7]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[8]  B. A. Carter,et al.  Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group , 2012 .

[9]  Jack Cuzick,et al.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. , 2011, Journal of the National Cancer Institute.

[10]  J. Cuzick,et al.  Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Caldas,et al.  A population-based validation of the prognostic model PREDICT for early breast cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  Andrew R. Green,et al.  MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups , 2011, Breast Cancer Research and Treatment.

[13]  K. Gelmon,et al.  Ki67 in breast cancer: prognostic and predictive potential. , 2010, The Lancet. Oncology.

[14]  Carlos Caldas,et al.  PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer , 2010, Breast Cancer Research.

[15]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[16]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[18]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[19]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[20]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[21]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[22]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Sugimura,et al.  The transcriptional inhibition of DNA repair protein Rad51 enhances radiosensitivity in prostate cancer cells , 2001 .

[24]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.